Changes in body composition in patients with chronic obstructive pulmonary disease: Do they influence patient-related outcomes?

Annals of Nutrition and Metabolism

Volumn 63, Issue 3, 2013, Pages 239-247

  Rutten, Erica P A ^a   Calverley, Peter M A ^b   Casaburi, Richard ^c   Agusti, Alvar ^d,e   Bakke, Per ^f   Celli, Bartolome ^g,h   Coxson, Harvey O ⁱ   Crim, Courtney ^j   Lomas, David A ^k   Macnee, William ^l   Miller, Bruce E ^j   Rennard, Stephan I ^m   Scanlon, Paul D ⁿ   Silverman, Edwin K ^g,h   Tal Singer, Ruth ^j   Vestbo, Jørgen ^o,p,q   Watkins, Michael L ^j   Wouters, Emiel F M ^r  

^a Program Development Centre   (Netherlands)

^b UNIVERSITY OF LIVERPOOL   (United Kingdom)

^c HARBOR UCLA MEDICAL CENTER   (United States)

^d UNIVERSITY OF BARCELONA   (Spain)

^e INSTITUTO DE SALUD CARLOS III   (Spain)

^f UNIVERSITY OF BERGEN   (Norway)

^g Brigham and Women's Hospital   (Norway)

^h HARVARD MEDICAL SCHOOL   (United States)

ⁱ UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^j GLAXOSMITHKLINE   (United States)

^k UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^l UNIVERSITY OF EDINBURGH   (United Kingdom)

^m UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

ⁿ MAYO CLINIC   (United States)

^o HVIDOVRE HOSPITAL   (Denmark)

^p UNIVERSITY OF COPENHAGEN   (Denmark)

^q UNIVERSITY OF MANCHESTER   (United Kingdom)

^r MAASTRICHT UNIVERSITY   (Netherlands)

more..

Author keywords

Body composition; Chronic obstructive pulmonary disease; Fat free mass index; Fat mass index; Health status; Mortality

Indexed keywords

ADULT; AGED; ARTICLE; BODY COMPOSITION; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; DISEASE COURSE; FAT FREE MASS; FAT MASS; FEMALE; FOLLOW UP; HEALTH STATUS; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MORTALITY; PRIORITY JOURNAL; SMOKING; UNDERWEIGHT; MUSCLE MASS; OBESITY; OUTCOME ASSESSMENT;

ADIPOSE TISSUE; AGED; BODY COMPOSITION; BODY WEIGHT; FEMALE; FOLLOW-UP STUDIES; HUMANS; LOGISTIC MODELS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; OBESITY; PROSPECTIVE STUDIES; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; THINNESS;

EID: 84890521927     PISSN: 02506807     EISSN: 14219697     Source Type: Journal    
DOI: 10.1159/000353211     Document Type: Article

References (31)

1. Lopez AD, et al: Chronic obstructive pulmonary disease: current burden and future projections. Eur Respir J 2006; 27: 397-412.
2. Rabe KF, et al: Update in chronic obstructive pulmonary disease 2006. Am J Respir Crit Care Med 2007; 175: 1222-1232.
3. Sin DD, Man SF: Why are patients with chronic obstructive pulmonary disease at increased risk of cardiovascular diseases? The potential role of systemic inflammation in chronic obstructive pulmonary disease. Circulation 2003; 107: 1514-1519.
4. Incalzi RA, et al: Chronic renal failure: a neglected comorbidity of COPD. Chest 2010; 137: 831-837.
5. Graat-Verboom L, et al: Current status of research on osteoporosis in COPD: a systematic review. Eur Respir J 2009; 34: 209-218.
6. Agusti A, et al: Characterisation of COPD heterogeneity in the ECLIPSE cohort. Respir Res 2010; 11: 122.
7. Chailleux E, Laaban JP, Veale D: Prognostic value of nutritional depletion in patients with COPD treated by long-Term oxygen therapy: data from the ANTADIR observatory. Chest 2003; 123: 1460-1466.
8. Toth S, et al: Nutritional depletion in relation to mortality in patients with chronic respiratory insufficiency treated with long-Term oxygen therapy. Wien Klin Wochenschr 2004; 116: 617-621.
9. Hallin R, et al: Nutritional status and longterm mortality in hospitalised patients with chronic obstructive pulmonary disease (COPD). Respir Med 2007; 101: 1954-1960.
10. Schols AM, et al: Body composition and mortality in chronic obstructive pulmonary disease. Am J Clin Nutr 2005; 82: 53-59.
11. Vestbo J, et al: Body mass, fat-free body mass, and prognosis in patients with chronic obstructive pulmonary disease from a random population sample: findings from the Copenhagen City Heart Study. Am J Respir Crit Care Med 2006; 173: 79-83.
12. Ferrari R, et al: Three-year follow-up study of respiratory and systemic manifestations of chronic obstructive pulmonary disease. Braz J Med Biol Res 2011; 44: 46-52.
13. Mostert R, et al: Tissue depletion and health related quality of life in patients with chronic obstructive pulmonary disease. Respir Med 2000; 94: 859-867.
14. Sundh J, et al: Co-morbidity, body mass index and quality of life in COPD using the clinical COPD questionnaire. COPD 2011; 8: 173-181.
15. Landbo C, et al: Prognostic value of nutritional status in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1999; 160: 1856-1861.
16. Prescott E, et al: Prognostic value of weight change in chronic obstructive pulmonary disease: results from the Copenhagen City Heart Study. Eur Respir J 2002; 20: 539-544.
17. van den Borst B, et al: Is age-related decline in lean mass and physical function accelerated by obstructive lung disease or smoking? Thorax 2011; 66: 961-969.
18. Vestbo J, et al: Evaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints (ECLIPSE). Eur Respir J 2008; 31: 869-873.
19. Celli BR, MacNee W: Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J 2004; 23: 932-946.
20. Steiner MC, et al: Bedside methods versus dual energy X-ray absorptiometry for body composition measurement in COPD. Eur Respir J 2002; 19: 626-631.
21. VanItallie TB, et al: Height-normalized indices of the body's fat-free mass and fat mass: potentially useful indicators of nutritional status. Am J Clin Nutr 1990; 52: 953-959.
22. Rutten EPA, Spruit MA, Wouters EFM: Critical view on diagnosing muscle wasting by single-frequency bio-electrical impedance in COPD. Respir Med 2010; 104: 91-98.
23. Jones PW, et al: A self-complete measure of health status for chronic airflow limitation. The St. George's Respiratory Questionnaire. Am Rev Respir Dis 1992; 145: 1321-1327.
24. Jones PW: Issues concerning health-related quality of life in COPD. Chest 1995; 107(suppl 5):187S-193S.
25. Hopkinson NS, et al: A prospective study of decline in fat free mass and skeletal muscle strength in chronic obstructive pulmonary disease. Respir Res 2007; 8: 25.
26. Lamprecht B, et al: COPD in never smokers: results from the population-based burden of obstructive lung disease study. Chest 2011; 139: 752-763.
27. Ischaki E, et al: Body mass and fat-free mass indices in COPD: relation with variables expressing disease severity. Chest 2007; 132: 164-169.
28. Jones PW, et al: Health status in the TORCH study of COPD: treatment efficacy and other determinants of change. Respir Res 2011; 12: 71.
29. Hanania NA, et al: Acute bronchodilator responsiveness and health outcomes in COPD patients in the UPLIFT trial. Respir Res 2011; 12: 6.
30. Whitlock G, et al: Body-mass index and cause-specific mortality in 900000 adults: collaborative analyses of 57 prospective studies. Lancet 2009; 373: 1083-1096.
31. Pocock SJ, et al: Weight loss and mortality risk in patients with chronic heart failure in the candesartan in heart failure: assessment of reduction in mortality and morbidity (CHARM) programme. Eur Heart J 2008; 29: 2641-2650.